CB-01-12
/ Cosmo Pharma
- LARVOL DELTA
Home
Next
Prev
1 to 3
Of
3
Go to page
1
May 24, 2024
Transcriptome and Metabolome Reveal Key Genes from the Plant Hormone Signal Transduction Pathway Regulating Plant Height and Leaf Size in Capsicum baccatum.
(PubMed, Cells)
- "This research conducted comparative transcriptome analyses using Capsicum baccatum germplasm HNUCB0112 and HNUCB0222 and their F2 generation as materials...Differential genes were verified by qRT-PCR, which was consistent with the RNA-Seq results, demonstrating the accuracy of the sequencing results. These results enhance our understanding of the developmental regulatory networks governing pepper key traits like plant height and leaf size and offer new information for future research on the pepper plant architecture system."
Journal
August 19, 2014
Salix Announces early termination of HSR waiting period for pending transaction
(Salix Press Release)
- "Salix...announced that it has received notice of the early termination of the waiting period for U.S. antitrust review...Completion of the transaction remains subject to approval by Salix’s stockholders and certain other closing conditions."
Anticipated M & A • Inflammatory Bowel Disease
October 03, 2014
Salix calls off inversion deal amid U.S. government crackdown
(Reuters)
- "Salix Pharmaceuticals ...citing a 'changed political environment,' said on Friday it had scrapped a deal with Italy's Cosmo Pharmaceuticals...that would have allowed it to shift its tax base from the United States to Europe....Shares of Salix were up 5 percent at $158.50 in premarket trading, reflecting investors' hopes that calling off an inversion makes a sale of the company more likely."
M&A • Inflammatory Bowel Disease
1 to 3
Of
3
Go to page
1